| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,243,373 | 1,242,978 | 1,558,535 | 2,142,770 | | Cost of Revenue | 886,904 | 960,093 | 1,204,093 | 1,683,935 | | | Gross Profit | 356,469 | 282,885 | 354,442 | 458,835 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 251,761 | 247,875 | 276,634 | 303,481 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 30,425 | 29,580 | 29,847 | 28,104 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 74,283 | 5,430 | 47,961 | 127,250 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,144 | 1,832 | 1,924 | 26,289 | | Earnings Before Interest And Taxes | 77,427 | 7,262 | 49,885 | 152,681 | | Interest Expense | 15,916 | 16,698 | 19,316 | 55,077 | | Income Before Tax | 61,511 | (9,436) | 30,569 | 97,604 | | Income Tax Expense | 19,434 | (3,880) | 10,181 | 31,316 | | Minority Interest | (821) |
-
|
-
| (858) | | | | Net Income From Continuing Ops | 41,256 | (5,556) | 20,388 | 66,288 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,256 | (5,556) | 20,388 | 66,288 | | Preferred Stock And Other Adjustments | 501 | (231) | (270) |
-
| | | Net Income Applicable To Common Shares | $41,757 | ($5,787) | $20,118 | $66,288 |
|
0.51% Nasdaq 
Income Statement
